Literature DB >> 28258954

Prevalence and Predicting Factors for Commonly Neglected Sexual Side Effects to External-Beam Radiation Therapy for Prostate Cancer.

Anders Frey1, Christian Pedersen2, Henriette Lindberg3, Rasmus Bisbjerg4, Jens Sønksen4, Mikkel Fode5.   

Abstract

INTRODUCTION: Changes in sexual function other than erectile dysfunction are sparsely investigated after radiation therapy for prostate cancer. AIM: To investigate orgasmic dysfunction, urinary incontinence during sexual activity, changes in penile morphology, and sensory disturbances in the penis in patients with prostate cancer treated with external-beam radiation therapy (EBRT).
METHODS: In February 2015, men treated with EBRT at our center 3 months to 5 years previously (N = 519) received a study-specific questionnaire. This was developed from purpose-built questions and validated tools including the Erection Hardness Scale. All patients had received a radiation dose of 78 Gy. Androgen deprivation therapy was administered according to disease characteristics. MAIN OUTCOME MEASURES: Outcome measurements were prevalence rates and predictors of these side effects as identified by multivariate logistic regression analyses.
RESULTS: One hundred nine patients were eligible (sexually active and had completed androgen deprivation therapy) for inclusion. Twenty-four percent reported anorgasmia, 44% reported a decreased intensity of their orgasms, and 40% reported that the time it took to reach orgasm had increased. Eleven percent reported anejaculation. Fifteen percent reported orgasm-associated pain. Only 4% reported urinary incontinence during sexual activity. Subjective penile length loss in excess of 1 cm was reported by 42%. Twelve percent reported an altered curvature of their penis after EBRT. Six percent reported painful erections. Twenty-seven percent reported decreased sensitivity in the penis after EBRT, 2% reported a cold sensation, and 2% reported paresthesia. Increasing time since final treatment increased the risk of penile sensory disturbances (odds ratio = 1.05; P = .028).
CONCLUSION: Orgasmic dysfunction, changes in penile morphology, and sensory disturbances in the penis are common side effects of ERBT. Patients should be properly informed of the occurrence of these side effects before deciding which treatment to pursue. Frey A, Pedersen C, Lindberg H, et al. Prevalence and Predicting Factors for Commonly Neglected Sexual Side Effects to External-Beam Radiation Therapy for Prostate Cancer. J Sex Med 2017;14:558-565.
Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Climacturia; External-Beam Radiation Therapy; Orgasm; Penile Shortening; Prostate Cancer; Sexual Dysfunction

Mesh:

Year:  2017        PMID: 28258954     DOI: 10.1016/j.jsxm.2017.01.015

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  10 in total

Review 1.  Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities).

Authors:  Marigdalia K Ramirez-Fort; Marc J Rogers; Roberto Santiago; Sean S Mahase; Melissa Mendez; Yi Zheng; Xiang Kong; James A Kashanian; M Junaid Niaz; Shearwood McClelland; Xiaodong Wu; Neil H Bander; Peter Schlegel; John P Mulhall; Christopher S Lange
Journal:  Rep Pract Oncol Radiother       Date:  2020-03-19

Review 2.  Sexual function and rehabilitation after radiation therapy for prostate cancer: a review.

Authors:  David-Dan Nguyen; Alejandro Berlin; Andrew G Matthew; Nathan Perlis; Dean S Elterman
Journal:  Int J Impot Res       Date:  2021-01-06       Impact factor: 2.896

Review 3.  Sexual function outcomes following interventions for prostate cancer: are contemporary reports on functional outcomes misleading?

Authors:  Catherine E Lovegrove; Vincenzo Ficarra; Francesco Montorsi; James N'Dow; Andrea Salonia; Suks Minhas
Journal:  Int J Impot Res       Date:  2019-12-13       Impact factor: 2.896

Review 4.  Neglected side effects to curative prostate cancer treatments.

Authors:  Alexander B Nolsøe; Christian Fuglesang S Jensen; Peter B Østergren; Mikkel Fode
Journal:  Int J Impot Res       Date:  2020-12-14       Impact factor: 2.896

Review 5.  Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment.

Authors:  Ibrahim A Abdel-Hamid; Omar I Ali
Journal:  World J Mens Health       Date:  2018-01       Impact factor: 5.400

Review 6.  Mapping the prevalence and use of questionnaires to detect the neglected sexual side effects after prostate cancer treatment: a scoping review.

Authors:  Pierre Röscher; Ronisha Sathiram; Joanne E Milios; Jacqueline M van Wyk
Journal:  Syst Rev       Date:  2022-01-03

Review 7.  Pharmacologic Management of Persistent Pain in Cancer Survivors.

Authors:  Paul Glare; Karin Aubrey; Amitabh Gulati; Yi Ching Lee; Natalie Moryl; Sarah Overton
Journal:  Drugs       Date:  2022-02-17       Impact factor: 9.546

Review 8.  Climacturia: a comprehensive review assessing pathophysiology, prevalence, impact, and treatment options regarding the "leak of pleasure".

Authors:  Ioannis Mykoniatis; Koenraad van Renterghem; Ioannis Sokolakis; Georgios Hatzichristodoulou; Maxime Sempels; Robert Andrianne
Journal:  Int J Impot Res       Date:  2020-03-17       Impact factor: 2.896

9.  Mapping the prevalence of the neglected sexual side effects after prostate cancer treatment and the questionnaires used in their screening: a scoping review protocol.

Authors:  Pierre Röscher; Jacqueline M van Wyk
Journal:  Syst Rev       Date:  2020-09-17

10.  A modified Delphi study to identify screening items to assess neglected sexual side-effects following prostate cancer treatment.

Authors:  Pierre Röscher; Kimesh Naidoo; Joanne E Milios; Jacqueline M van Wyk
Journal:  BMC Urol       Date:  2022-03-11       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.